| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 2, Issue 8 365-372, Copyright © 1991 by American Association of Cancer Research
ARTICLES |
CL Sommers, EW Thompson, JA Torri, R Kemler, EP Gelmann and SW Byers
Vincent T. Lombardi Cancer Research Center, Washington, DC.
Loss of cell-cell adhesion in carcinoma cells may be an important step in the acquisition of an invasive, metastatic phenotype. We have examined the expression of the epithelial-specific cell adhesion molecule uvomorulin (E-cadherin, cell-CAM 120/80, L-CAM) in human breast cancer cell lines. We find that fibroblastoid, highly invasive, vimentin-expressing breast cancer cell lines do not express uvomorulin. Of the more epithelial-appearing, less invasive, keratin-expressing breast cancer cell lines, some express uvomorulin, and some do not. We examined the morphologies of the cell lines in the reconstituted basement membrane matrix Matrigel and measured the ability of the cells to traverse a Matrigel-coated filter as in vitro models for detachment of carcinoma cells from neighboring cells and invasion through basement membrane into surrounding tissue. Colonies of uvomorulin-positive cells have a characteristic fused appearance in Matrigel, whereas uvomorulin-negative cells appear detached. Cells which are uvomorulin negative and vimentin positive have a stellate morphology in Matrigel. We show that uvomorulin is responsible for the fused colony morphology in Matrigel since treatment of uvomorulin-positive MCF-7 cells with an antibody to uvomorulin caused the cells to detach from one another but did not induce invasiveness in these cells, as measured by their ability to cross a Matrigel-coated polycarbonate filter in a modified Boyden chamber assay. Two uvomorulin-negative, vimentin-negative cell lines are also not highly invasive as measured by this assay. We suggest that loss of uvomorulin-mediated cell-cell adhesion may be one of many changes involved in the progression of a carcinoma cell to an invasive phenotype.
This article has been cited by other articles:
![]() |
M. U. Naik, T. U. Naik, A. T. Suckow, M. K. Duncan, and U. P. Naik Attenuation of Junctional Adhesion Molecule-A Is a Contributing Factor for Breast Cancer Cell Invasion Cancer Res., April 1, 2008; 68(7): 2194 - 2203. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Shin, N. Sanchez-Velar, D. H. Sherr, and G. E. Sonenshein 7,12-Dimethylbenz(a)Anthracene Treatment of a c-rel Mouse Mammary Tumor Cell Line Induces Epithelial to Mesenchymal Transition via Activation of Nuclear Factor-{kappa}B. Cancer Res., March 1, 2006; 66(5): 2570 - 2575. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Platica, E. Ivan, J. F. Holland, A. Ionescu, S. Chen, J. Mandeli, P. D. Unger, and O. Platica A pituitary gene encodes a protein that produces differentiation of breast and prostate cancer cells PNAS, February 10, 2004; 101(6): 1560 - 1565. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S.T. Wong and B. M. Gumbiner Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin J. Cell Biol., June 23, 2003; 161(6): 1191 - 1203. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gilles, M. Polette, M. Mestdagt, B. Nawrocki-Raby, P. Ruggeri, P. Birembaut, and J.-M. Foidart Transactivation of Vimentin by {beta}-Catenin in Human Breast Cancer Cells Cancer Res., May 15, 2003; 63(10): 2658 - 2664. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shah, M. J. Pishvaian, V. Easwaran, P. H. Brown, and S. W. Byers The Role of Cadherin, beta -Catenin, and AP-1 in Retinoid-regulated Carcinoma Cell Differentiation and Proliferation J. Biol. Chem., July 5, 2002; 277(28): 25313 - 25322. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Weng, M. Xin, L. Pablo, D. Grueneberg, M. Hagel, G. Bain, T. Muller, and J. Papkoff Protection against Anoikis and Down-regulation of Cadherin Expression by a Regulatable beta -Catenin Protein J. Biol. Chem., May 17, 2002; 277(21): 18677 - 18686. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Zajchowski, M. F. Bartholdi, Y. Gong, L. Webster, H.-L. Liu, A. Munishkin, C. Beauheim, S. Harvey, S. P. Ethier, and P. H. Johnson Identification of Gene Expression Profiles That Predict the Aggressive Behavior of Breast Cancer Cells Cancer Res., July 1, 2001; 61(13): 5168 - 5178. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Troxell, D. Loftus, W. Nelson, and J. Marrs Mutant cadherin affects epithelial morphogenesis and invasion, but not transformation J. Cell Sci., January 3, 2001; 114(6): 1237 - 1246. [Abstract] [PDF] |
||||
![]() |
R. B. Hazan, G. R. Phillips, R. F. Qiao, L. Norton, and S. A. Aaronson Exogenous Expression of N-Cadherin in Breast Cancer Cells Induces Cell Migration, Invasion, and Metastasis J. Cell Biol., February 21, 2000; 148(4): 779 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Graff, E. Gabrielson, H. Fujii, S. B. Baylin, and J. G. Herman Methylation Patterns of the E-cadherin 5' CpG Island Are Unstable and Reflect the Dynamic, Heterogeneous Loss of E-cadherin Expression during Metastatic Progression J. Biol. Chem., January 28, 2000; 275(4): 2727 - 2732. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Nieman, R. S. Prudoff, K. R. Johnson, and M. J. Wheelock N-Cadherin Promotes Motility in Human Breast Cancer Cells Regardless of Their E-Cadherin Expression J. Cell Biol., November 1, 1999; 147(3): 631 - 644. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Orford, C. C. Orford, and S. W. Byers Exogenous Expression of {beta}-Catenin Regulates Contact Inhibition, Anchorage-Independent Growth, Anoikis, and Radiation-Induced Cell Cycle Arrest J. Cell Biol., August 23, 1999; 146(4): 855 - 868. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pötter, C. Bergwitz, and G. Brabant The Cadherin-Catenin System: Implications for Growth and Differentiation of Endocrine Tissues Endocr. Rev., April 1, 1999; 20(2): 207 - 239. [Abstract] [Full Text] |
||||
![]() |
M. J. Pishvaian, C. M. Feltes, P. Thompson, M. J. Bussemakers, J. A. Schalken, and S. W. Byers Cadherin-11 Is Expressed in Invasive Breast Cancer Cell Lines Cancer Res., February 1, 1999; 59(4): 947 - 952. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Nawrocki, M. Polette, J. Van Hengel, J.-M. Tournier, F. Van Roy, and P. Birembaut Cytoplasmic Redistribution of E-Cadherin-Catenin Adhesion Complex Is Associated with Down-Regulated Tyrosine Phosphorylation of E-Cadherin in Human Bronchopulmonary Carcinomas Am. J. Pathol., November 1, 1998; 153(5): 1521 - 1530. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Hazan and L. Norton The Epidermal Growth Factor Receptor Modulates the Interaction of E-cadherin with the Actin Cytoskeleton J. Biol. Chem., April 10, 1998; 273(15): 9078 - 9084. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Hazan, L. Kang, S. Roe, P. I. Borgen, and D. L. Rimm Vinculin Is Associated with the E-cadherin Adhesion Complex J. Biol. Chem., December 19, 1997; 272(51): 32448 - 32453. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Graff, J. G. Herman, S. Myohanen, S. B. Baylin, and P. M. Vertino Mapping Patterns of CpG Island Methylation in Normal and Neoplastic Cells Implicates Both Upstream and Downstream Regions in de Novo Methylation J. Biol. Chem., August 29, 1997; 272(35): 22322 - 22329. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Kester, B.-j. M. van der Leede, P. T. van der Saag, and B. van der Burg Novel Progesterone Target Genes Identified by an Improved Differential Display Technique Suggest That Progestin-induced Growth Inhibition of Breast Cancer Cells Coincides with Enhancement of Differentiation J. Biol. Chem., June 27, 1997; 272(26): 16637 - 16643. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Chen, N. Paradies, M Fedor-Chaiken, and R Brackenbury E-cadherin mediates adhesion and suppresses cell motility via distinct mechanisms J. Cell Sci., January 2, 1997; 110(3): 345 - 356. [Abstract] [PDF] |
||||
![]() |
S. Byers, C. Sommers, B Hoxter, A. Mercurio, and A Tozeren Role of E-cadherin in the response of tumor cell aggregates to lymphatic, venous and arterial flow: measurement of cell-cell adhesion strength J. Cell Sci., January 5, 1995; 108(5): 2053 - 2064. [Abstract] [PDF] |
||||
![]() |
W.B. Isaacs, G.S. Bova, R.A. Morton, M.J.G. Bussemakers, J.D. Brooks, and C.M. Ewing Genetic Alterations in Prostate Cancer Cold Spring Harb Symp Quant Biol, January 1, 1994; 59(0): 653 - 659. [Abstract] [PDF] |
||||
![]() |
D. Chu, N. Kakazu, M. J. Gorrin-Rivas, H.-P. Lu, M. Kawata, T. Abe, K. Ueda, and Y. Adachi Cloning and Characterization of LUN, a Novel RING Finger Protein That Is Highly Expressed in Lung and Specifically Binds to a Palindromic Sequence J. Biol. Chem., April 20, 2001; 276(17): 14004 - 14013. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |